title: Needs assessment and treatment compliance at state opioid substitution treatment programes in Georgia.
abstract: conduct needs assessments and treatment compliance evaluations in MMT and Suboxone Substitution State Programs in Georgia (Republic of). 506 patients (2 females) were surveyed (92% on Methadone, 8% on Suboxone) from 6 Tbilisi and 4 regional State Programs in 2011 November. Mean age - 40±8,56 (22-65) year; 254 (51.4%) were in treatment for 1-3 year. Evaluation was carried out on the base of structured self-questionnaire that covers demographics, drug use history, general drug use trends, psychotherapeutic sessions' acceptance and open label question regarding treatment challenges and satisfaction. 305 (60.3%) attended individual and 57 (11.3%) group psychotherapy sessions with 50.79% attending once/month or rare. The main reason given for therapy non-attendance - no needs for it (29.48%); the main drugs before admission - heroin (80.04%), buprenorphine (53.49%); Main drugs used in Georgia nowadays - desomorphine ("crocodile"), alcohol and marihuana. Commonly used drugs by program patients (136 positive answers) - alcohol-13.62%, marihuana-10.39%, pregabalin - 8.17%, opioids- 6.62% (mostly-"crocodile"), home-made stimulants-6.23%, sedatives -5.45%. 55.4% are extremely satisfied with treatment, 82.4% - with program staff. Patients' main wishes- free of charge programs (46.4%) and provide take-home doses (22.07%). Methadone and Suboxone ST are being well accepted in Georgia and appear to be reducing illegal opioid use. However, the psychotherapeutic sessions' attendance is very low.
authors: Center for Mental Health and Prevention of Addiction, Tbilisi, Georgia.
authors: G
authors: G
authors: Piralishvili
authors: I
authors: I
authors: Gamkrelidze
authors: N
authors: N
authors: Nikolaishvili
authors: M
authors: M
authors: Chavchanidze
mesh_terms: D000328:Adult; D000368:Aged; D002047:Buprenorphine / Q000627:therapeutic use; D000069479:Buprenorphine, Naloxone Drug Combination; D005260:Female; D005846:Georgia (Republic) / Q000453:epidemiology; D006078:Government Programs; D006556:Heroin Dependence / Q000453:epidemiology; D006801:Humans; D006993:Hypnotics and Sedatives; D008297:Male; D002189:Marijuana Abuse / Q000453:epidemiology; D008691:Methadone / Q000627:therapeutic use; D008875:Middle Aged; D009270:Naloxone / Q000627:therapeutic use; D020380:Needs Assessment; D058850:Opiate Substitution Treatment / Q000379:methods*; D010349:Patient Compliance; D017060:Patient Satisfaction; D011613:Psychotherapy; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000453:epidemiology; D011795:Surveys and Questionnaires; D055815:Young Adult
chemical_list: D000069479:Buprenorphine, Naloxone Drug Combination; D006993:Hypnotics and Sedatives; D009270:Naloxone; D002047:Buprenorphine; D008691:Methadone